Explore 130+ historical metrics & ratios
Compare equities side by side
Stocks breaking to new annual highs
S&P 500 oversold value screener
Relative strength momentum leaders
Upcoming earnings dates & reports
Filter and sort all 500 stocks
Today's biggest gainers and losers
Visual sector performance
| Reported | Consensus estimates | ||||||
|---|---|---|---|---|---|---|---|
| Fiscal period | FY2023Dec '23 | FY2024Dec '24 | FY2025Dec '25 | FY2026Dec '26 | FY2027Dec '27 | FY2028Dec '28 | FY2029Dec '29 |
| Revenue (B) | 3.89 | 3.94 | 4.62 | 35.46 | 38.31 | 40.87 | 40.56 |
| Growth YoY | −7.0% | +1.2% | +17.1% | +668.2% | +8.0% | +6.7% | −0.8% |
| High estimate | – | – | – | 35.87 | 39.20 | 43.05 | 42.00 |
| Low estimate | – | – | – | 34.29 | 36.04 | 38.94 | 39.41 |
| Analysts | – | – | – | 19 | 20 | 21 | 10 |
| EPS, adjusted | 0.44 | 0.63 | 0.84 | 5.87 | 6.33 | 6.98 | 7.48 |
| Growth YoY | +30.8% | +44.8% | +32.8% | +597.8% | +7.7% | +10.4% | +7.1% |
| High estimate | – | – | – | 6.06 | 6.58 | 9.37 | 7.82 |
| Low estimate | – | – | – | 5.75 | 6.07 | 6.16 | 7.20 |
| Analysts | – | – | – | 14 | 14 | 13 | 10 |
Consensus mean of analyst estimates. EPS is adjusted (street) EPS, the basis analysts forecast; annual actuals are the sum of the four reported quarters. Growth compares with the same period a year earlier; n/m where the prior period was a loss.
| Firm | Analyst | Rating | Prev rating | Target | Prev target | Chg | Upside | Date |
|---|---|---|---|---|---|---|---|---|
| Nomura | Rachel Guo | – | – | $10.00 | – | – | +10% | Aug 13 |
| China Renaissance | – | Hold | Buy | – | – | – | – | Aug 12 |
| Mizuho | – | Outperform | Outperform | – | – | – | – | Aug 12 |
| UBS | Wei Xiong | Neutral · Mar 2026 | Buy | $15.00 | $13.00 | +15% | +66% | Aug 12 |
| JP Morgan | – | Neutral | Neutral | – | – | – | – | May 14 |
| Barclays | – | Overweight | Overweight | – | – | – | – | Mar 19 |
| Benchmark | – | Hold | Buy | – | – | – | – | Mar 18 |
| Jefferies | Thomas Chong | Buy · Aug 2019 · not counted | Buy | $23.00 | $16.00 | +44% | +154% | Mar 17 |
| Macquarie | Ellie Jiang | Neutral · Mar 2026 | Outperform | $10.70 | $29.80 | −64% | +18% | Mar 17 |
| 86Research | Charlie Chai | – | – | $17.40 | $12.00 | +45% | +92% | Mar 6 |
| Morgan Stanley | – | Overweight | Overweight | $25.00 | $13.00 | +92% | +176% | Dec 22, 2025 |
Latest analyst action Page refreshed hourly; analyst feeds refreshed dailyAbout this data